Cargando…
A phosphodiesterase-4 inhibitor reduces lung inflammation and fibrosis in a hamster model of SARS-CoV-2 infection
INTRODUCTION: The Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) infection involves pulmonary inflammation that can progress to acute respiratory distress syndrome, a primary cause of lung damage/fibrosis in patients with Coronavirus Disease-2019 (COVID-19). Currently, there is no effi...
Autores principales: | Kolloli, Afsal, Ramasamy, Santhamani, Kumar, Ranjeet, Nisa, Annuurun, Kaplan, Gilla, Subbian, Selvakumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580809/ https://www.ncbi.nlm.nih.gov/pubmed/37854602 http://dx.doi.org/10.3389/fimmu.2023.1270414 |
Ejemplares similares
-
Thalidomide and Phosphodiesterase 4 Inhibitors as Host Directed Therapeutics for Tuberculous Meningitis: Insights From the Rabbit Model
por: Kumar, Ranjeet, et al.
Publicado: (2020) -
An intra-cytoplasmic route for SARS-CoV-2 transmission unveiled by Helium-ion microscopy
por: Merolli, Antonio, et al.
Publicado: (2022) -
Comprehensive Analysis of Disease Pathology in Immunocompetent and Immunocompromised Hosts following Pulmonary SARS-CoV-2 Infection
por: Ramasamy, Santhamani, et al.
Publicado: (2022) -
Inactivation and Elimination of SARS-CoV-2 in Biosamples Using Simple Fixatives and Ultrafiltration
por: Kumar, Ranjeet, et al.
Publicado: (2021) -
Aggregation state of Mycobacterium tuberculosis impacts host immunity and augments pulmonary disease pathology
por: Kolloli, Afsal, et al.
Publicado: (2021)